Join A&M Healthcare Industry Group's Marthe Haverkamp, M.D., Ph.D, as she sits down with world-renowned virologist Ab Osterhaus, Ph.D., and vaccine expert Manon Cox, Ph.D., MBA, Chief Executive Officer and Co-Founder of NextWaveBio. They discuss the future of vaccines, the value of COVID-19 treatments, and the influence of Omicron on the pandemic: Is a relatively mild disease now a comparative advantage for the future?
https://www.alvarezandmarsal.com/insights/is-omicron-our-way-out
With the current pressures on healthcare workers, doctors and residents are now unionizing. On our The Future of Healthcare Human Capital and Workforce Management...
In response to HHS-OIG's increased focus on Medicare Advantage organizations resulting in compliance audits, A&M Healthcare Industry Group's Ron Vance, Managing Director and Co-Head...
The rise in cybersecurity attacks throughout the pandemic has been felt across the healthcare industry. Healthcare organizations have had to pivot their cybersecurity strategies...
